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Hypospadias is a congenital abnormality of
the male genitalia characterized by incomplete
development of the urethra so that the exter-
nal urethral opening (meatus) is on the ventral
surface of the penis or on the scrotum, rather
than at the tip of the penis. Hypospadias,
particularly when proximal, is often accompa-
nied by chordee, curvature of the penis. The
more proximal the location and the greater
the associated chordee, the more functional
impairment results. In some glanular cases,
the deformity is only cosmetic.
There is some evidence that the prevalence
of hypospadias has been increasing in the
1960s, 1970s, and 1980s in Europe (Czeizel
1985; Kallen and Winberg 1982; Matlai and
Beral 1985; Paulozzi 1999; Toppari et al.
1996) and in the United States (Paulozzi et al.
1997), although recent reports suggest that
these trends might not be continuing (Paulozzi
1999; Toppari et al. 1996). At the same time
as hypospadias prevalence has appeared to be
rising, increases in the incidence of related
abnormalities such as cryptorchidism (unde-
scended testes) and testicular cancer have been
reported, as well as a fall in male fertility
(Sharpe and Skakkebaek 1993). Although
there are problems with the interpretation of
the epidemiologic data on trends for all the
various disorders, the concomitant increase in
apparently etiologically related disorders has
tended to strengthen the interpretation of
these changes as real phenomena. The possibil-
ity is under active investigation that the under-
lying cause of the change in frequency of all
these conditions, as well as reproductive abnor-
malities observed in fish and other animals,
may be exposure to endocrine-disrupting
chemicals (Burdorf and Nieuwenhuisen 1999;
Colborn 1995; Joffe 2001; Sharpe and
Skakkebaek 1993; Toppari et al. 1996). In
relation to hypospadias, evidence suggests that
an antiandrogen mechanism (one that ham-
pers the activity of male hormones) would be
most likely (Baskin et al. 2001).
Concern about widespread exposure to
endocrine-disrupting chemicals should lead us
to evaluate the effectiveness of current popula-
tion surveillance of potential adverse health
outcomes, including hypospadias. One of the
main difficulties in reliably documenting
changes in prevalence of hypospadias is the
relatively common occurrence of more distal
forms compared with severe forms, and the
potential for incomplete, inaccurate, or incon-
sistent diagnosis and reporting of the more
distal forms (Aho et al. 2000; Dolk 1998;
Paulozzi 1999).
The EUROCAT (European Surveillance
of Congenital Anomalies) network of popula-
tion-based congenital anomaly registers is the
main source of epidemiologic surveillance data
on congenital anomalies in Europe. Data are
available from 1980 (EUROCAT Working
Group 2002). The EUROCAT guidelines
specify that hypospadias is to be registered
with the exclusion of the most distal cases
where the meatus lies before the coronary
sulcus, glanular or first-degree hypospadias.
The National Congenital Anomaly System
(NCAS) is a national system for the reporting
of congenital anomalies in England and Wales
and was the source of one of the early reports
of a rising trend in hypospadias prevalence
(Matlai and Beral 1985). Since 1990, NCAS
has operated the EUROCAT exclusion guide-
line for distal hypospadias. In this study
we aimed a) to document the prevalence of
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Concern about apparent increases in the prevalence of hypospadias—a congenital male reproductive-
tract abnormality—in the 1960s to 1980s and the possible connection to increasing exposures to
endocrine-disrupting chemicals have underlined the importance of effective surveillance of hypo-
spadias prevalence in the population. We report here the prevalence of hypospadias from 1980 to
1999 in 20 regions of Europe with EUROCAT (European Surveillance of Congenital Anomalies)
population-based congenital anomaly registers, 14 of which implemented a guideline to exclude
glanular hypospadias. We also report data from the England and Wales National Congenital
Anomaly System (NCAS). Our results do not suggest a continuation of rising trends of hypo-
spadias prevalence in Europe. However, a survey of the registers and a special validation study
conducted for the years 1994–1996 in nine EUROCAT registers as well as NCAS identified a
clear need for a change in the guidelines for registration of hypospadias. We recommend that all
hypospadias be included in surveillance, but that information from surgeons be obtained to verify
location of the meatus, and whether surgery was performed, in order to interpret trends. Investing
resources in repeated special surveys may be more cost-effective than continuous population sur-
veillance. We conclude that it is doubtful whether we have had the systems in place worldwide for
the effective surveillance of hypospadias in relation to exposure to potential endocrine-disrupting
chemicals. Key words: endocrine-disrupting chemicals, Europe, hypospadias, prevalence, sur-
veillance. Environ Health Perspect 112:398–402 (2004). doi:10.1289/ehp.6398 available via
http://dx.doi.org/ [Online 18 November 2003]
hypospadias recorded by EUROCAT registries
and NCAS since 1980, b) to investigate the
effectiveness of the current EUROCAT exclu-
sion guideline for hypospadias surveillance,
and c) to make recommendations for the
surveillance of hypospadias.
Materials and Methods
EUROCAT registries are regional popula-
tion-based registries actively ascertaining
congenital anomalies from multiple sources.
Descriptions of EUROCAT registries are
available elsewhere (EUROCAT Working
Group 2002). The EUROCAT list of minor
anomalies for exclusion specifies that cases of
hypospadias when the meatus lies before
the coronary sulcus, glanular or first-degree
hypospadias are to be excluded unless occur-
ring in combination with specified (major)
anomalies (EUROCAT Working Group
2001). Registries implement the EUROCAT
list of minor anomalies for exclusion either by
asking their notifiers not to notify these cases
and/or by excluding these cases before trans-
mission of data to the Central EUROCAT
Registry.
A questionnaire concerning hypospadias
registration practice was sent to all registries
(EUROCAT Working Group 2003). Nine
EUROCAT registries (Northern Netherlands;
Paris, France; Odense, Denmark; Basque
Country, Spain; Mainz, Germany; Vaud,
Switzerland; and Northeast Italy, Tuscany,
Emilia Romagna, Italy) participated in a spe-
cial retrospective validation study of cases in
live births between 1994 and 1996, surviving
the first week of life, and without chromo-
somal anomalies. Data collection for this vali-
dation study took place in 1999–2000. The
nine registries contacted the pediatric surgeons
who had treated the hypospadias cases, ask-
ing them to fill in a succinct questionnaire
relating to when operation was planned/
performed, and mark on the diagram the loca-
tion of hypospadias and degree of chordee.
The surgeons were also asked if they had
operated on any further eligible nonglanular
cases born 1994–1996 not known to the reg-
ister. In one of the nine registries (Mainz),
extra standardized examinations are carried
out on all newborns by registry pediatricians
for registration and research purposes, and
information was obtained only from records
of these examinations.
The NCAS is not a EUROCAT registry
but a national voluntary congenital anomaly
notification system based on a notification
form filled out by health providers, usually in
the neonatal period. It was set up in 1964. In
1990, the EUROCAT list of minor anom-
alies for exclusion (including glanular hypo-
spadias) was implemented. We conducted a
small validation study in two phases. Case
lists from three pediatric surgery centers in
England for cases first operated on in 1996
and born 1993–1995 were compared with
NCAS registrations. Cases notified to the
NCAS from three health districts in England
(with geographical areas overlapping the
selected surgical centers) were followed up
with surgeons to verify case status and loca-
tion of hypospadias. Full details of this and
the EUROCAT validation study are available
(EUROCAT Working Group 2003), and
summary results are reported here.
Prevalence rates of hypospadias for 20
registries that had completed a questionnaire
concerning registration practice and that had
data at least as recent as 1998 covering a
period of at least 5 years were extracted from
the Central EUROCAT database in 2001 for
the period 1980–1999. England and Wales
NCAS data were extracted for the years
1980–1996. Prevalence rates were calculated
as the number of hypospadias cases registered
divided by the total number of live and still-
births (of either sex) in the population covered
by the register. Change in annual prevalence
rates over time was assessed by the chi-square
test for trend.
Some of the registries that are members of
the International Clearinghouse for Birth
Defect Monitoring Systems have contributed
to a previous publication of trends in preva-
lence rates for overlapping time periods
(England and Wales NCAS and the EURO-
CAT registries of Northeast Italy, Northern
Netherlands, Paris, Emilia Romagna, and
Dublin, Ireland; Paulozzi 1999).
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Table 1. Hypospadias prevalence per 1,000 births in EUROCAT registries, 1980–1999.
No. Prevalence 1980– 1985– 1990– 1995–
Registry Years of data of cases Total births per 1,000 1984 1989 1994 1999 Trenda
Implementing guideline to 
exclude glanular hypospadiasb,c
Antwerp, Belgium 1990–1999 78 108,753 0.7 — — 0.69 0.73 No trend
Hainaut, Belgiumd,e 1980–1999 248 214,340 1.2 0.93 1.31 1.06 1.30 No trend
Basque Country, Spaine 1990–1998 117 144,316 0.8 — — 0.85 0.77 No trend
Emilia Romagna, Italy 1981–1999 281 445,289 0.6 0.71 0.56 0.54 0.74 No trend
Northeast Italyc 1981–1999 554 894,344 0.6 0.76 0.72 0.64 0.45 ↓ p < 0.05
Galway, Ireland 1981–1999 24 54,509 0.4 0.22 0.20 0.62 0.77 ↑ p < 0.01
Northern Netherlands 1981–1999 285 288,012 1.0 1.73 0.87 0.90 0.92 ↓ p < 0.01
Odense, Denmark 1980–1999 121 105,848 1.1 1.30 0.85 0.95 1.45 No trend
Paris, Francee,f 1981–1999 839 698,681 1.2 1.05 1.10 1.63 1.00 No trend
Strasbourg, Francee 1982–1998 481 225,983 2.1 1.30 2.33 2.62 1.87 No trend
Changes in guideline 
implementationb or ascertainmentg
Glasgow, United Kingdomb,e 1980–1999 313 243,634 1.3 1.64 1.87 0.90 0.58 ↓ p < 0.05
Tuscany, Italyb 1980–1999 233 306,517 0.8 1.07 1.43 0.70 0.46 ↓ p < 0.05
Maltae,g 1986–1999 94 71,354 1.3 — 0.96 1.33 1.63 ↑ p < 0.05
Zagreb, Croatiag 1983–1999 111 103,255 1.1 0.99 1.52 1.09 0.64 ↓ p < 0.001
Not implementing guideline to 
exclude glanular hypospadias
Vaud, Switzerlandd,e 1988–1999 106 84,471 1.3 — 1.11 0.94 1.61 No trend
Styria, Austriad,e 1985–1999 269 192,348 1.4 — 0.75 2.11 1.32 ↑ p < 0.001
Dublin, Irelande 1980–1999 603 420,564 1.4 1.50 1.00 1.38 1.86 ↑ p < 0.01
Mainz, Germanyf,h 1990–1999 90 37,968 2.4 — — 2.85 1.83 ↓ p < 0.01
Saxony-Anhalt, Germany 1987–1999 236 143,044 1.6 — 1.45 1.73 1.78 No trend
Sicily, Italye 1991–1998 237 152,237 1.6 — — 1.61 1.50 No trend
a↑ = rising trend; ↓ = decreasing trend. bImplementation of exclusion guideline only since 1990 in Glasgow (previously registering glanular cases who had surgery), and since 1992 in
Tuscany. cNortheast Italy excludes glanular and coronal cases. dGlanular cases with surgery registered. eRegistry that obtains case notifications, among multiple sources, from pedi-
atric surgeons or hospital discharge records, including pediatric surgery. fParis and Mainz included 3 false positive cases. gZagreb included cases of unspecified location, and access
to information about location improved during the study period; Malta has obtained several new sources of information since 1993, including hospital activity analysis records covering
pediatric surgery discharges. hMainz conducts special standardized examination of all newborns for registration and research purposes.
Results
EUROCAT prevalence data 1980–1999: 20
registries. Fourteen of the 20 registries analyzed
were implementing the guideline to exclude
glanular cases or type 1 cases (Table 1). Of the
10 with consistent application of the guideline
over the time period, Northern Netherlands
and Northeast Italy recorded a decreasing trend
in prevalence, and Galway, Ireland, an increas-
ing trend. Prevalence in the two French regions
seemed to peak in the early 1990s with no over-
all trend. Three registries implemented the
guideline for only the latter part of the study
period and recorded a decreasing trend in
prevalence at least in part associated with this
change (Glasgow, Scotland; Tuscany; Zagreb,
Croatia; Table 1). An increasing trend in Malta
was associated at least in part with a change in
sources of information for case ascertainment
(Table 1). By 1995–1999, the total prevalence
across the 14 registries implementing the
guideline was 0.80 per 1,000 [95% confidence
interval (CI), 0.75–0.86], with significant vari-
ation (p < 0.001) between registries from 0.5 in
Tuscany to 1.9 in Strasbourg, France.
Six registries were not implementing the
guideline, two of these registering glanular
cases who had surgery (Vaud; Styria, Austria),
the other four registers registering all glanular
cases reported to them (Table 1). There was a
significant upward trend in two registries
(Styria and Dublin), although the prevalence
in Styria seemed to peak in the early 1990s.
There was a downward trend since 1990 in
Mainz. In 1995–1999, the total prevalence
rate across these registers was 1.64 (95% CI,
1.51–1.79) with a higher rate among those
registering all hypospadias (1.73 per 1,000;
95% CI, 1.57–1.91) than those registering
only those with surgery (1.43 per 1,000;
95% CI, 1.21–1.69).
EUROCAT validation study: nine reg-
istries. Of 382 cases that were included in the
EUROCAT validation survey in the nine par-
ticipating registers, 300 (78.5%) were isolated
hypospadias (i.e., not associated with major
nongenital system congenital anomalies) to
which the exclusion guideline applies. The
response rate from pediatric surgeons was
variable, and two registries (Emilia Romagna
and Northeast Italy) are excluded from com-
bined figures because they had response rates
below 50%. The response rates in the remain-
ing seven registries averaged 84% (76–78% in
Paris, Tuscany, and Northern Netherlands;
89% in Basque Country; 96–100% in Odense,
Mainz, and Vaud). It is possible that cases with
normal meatal position or not requiring surgery
were selectively among cases that could not be
followed up.
Contact with pediatric surgeons produced
extra case notifications indicating substantial
underascertainment in one of the registries
(20 of 45 isolated cases in Tuscany), suggest-
ing that the prevalence figures in Table 1 for
Tuscany are underestimated.
Six cases in total were found to have been
false positives, that is, not to have hypospadias:
three cases (4%) in Paris and three cases (11%)
of incomplete prepuce in Mainz.
Among the registries implementing
the guideline (Paris, Tuscany, Northern
Netherlands, Basque Country, Odense), two
registries found that some cases of glanular
hypospadias had been incorrectly included
among registered cases (11 of 47 cases of verified
location in Paris, 2 of 17 in Basque Country).
The two extra registries with low response rates
from pediatric surgeons also had incorrectly
registered glanular cases (2 of 12 cases of veri-
fied location in Emilia Romagna, 7 of 24 in
Northeast Italy). Prevalence figures in Table 1
for Paris and Northeast Italy thus need to be
interpreted in the light of the fact that glanular
cases had not been effectively excluded.
In the two registries not implementing the
guideline, the ratio of glanular to nonglanular
cases was 6:12 (Vaud) and 10:12 (Mainz), an
average of 40% of isolated hypospadias thus
being glanular.
England and Wales NCAS data. Figure 1
shows the yearly prevalence of hypospadias
based on NCAS data. From 1980 through
1989 there were 10,780 cases, giving an
average prevalence of 1.6 per 1,000 births.
Prevalence apparently peaked in 1983, coinci-
dentally also the final year of a previous publi-
cation (Matlai and Beral 1985) showing a
steeply rising trend in hypospadias prevalence
since 1964 (Figure 1). The prevalence from
1990, after implementation of the exclusion
criterion, declined to an average of 0.8 per
1,000 births in 1992–1996.
In three pediatric surgical centers, 159
children were identified who were born dur-
ing 1993–1995 and had their first operation
for hypospadias in 1996. Twenty-five percent
of cases were glanular. Of the 114 nonglanu-
lar cases eligible for notification to the NCAS,
a maximum of 26% had been notified to the
NCAS (including probable as well as exact
case matches).
In the three district health authorities
selected for study, 44 cases of hypospadias
born during 1993–1995 had been notified to
the NCAS. Seven (16%) of these were found
not to be hypospadias cases on follow-up, and
16 (36%) were glanular and therefore not
eligible for notification.
Age at surgery. Average age at first surgery
in the nine EUROCAT survey registries var-
ied from 1–2 years in Vaud (13.6 months),
Paris (16.4 months), Northern Netherlands
(19.5 months), and Mainz (22.4 months) to
2–3 years in Emilia Romagna (24.7 months),
Northeast Italy (34.0 months), Basque Country
(34.2 months), and Tuscany (36.0 months) to
5 years (61.0 months) in Odense. In the three
surgical centers in England contacted for the
NCAS validation study, the average age at first
operation was 30.0 months.
Discussion
It is a precondition for effective epidemiologic
surveillance of hypospadias that comparisons
over time and between countries should be
based on data comparable in definition and
ascertainment. We have shown variable quality
of surveillance data in Europe. We are aware of
two previous studies that have validated the
quality of surveillance data (Aho et al. 2000;
Kallen et al. 1986), also finding considerable
problems. We recommend caution in inter-
preting international trends (Paulozzi 1999),
whether for all hypospadias or “severe”
hypospadias.
It is a well-known phenomenon that the
existence of guidelines does not guarantee
their implementation or even their feasibility.
Six of the 20 EUROCAT registers in our
study were found not to be following the
EUROCAT guideline to exclude glanular
hypospadias. Lack of resources or reliable
access to appropriate sources of clinical infor-
mation on location of hypospadias led some
registries not to implement the guideline and
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Figure 1. Hypospadias prevalence rates by year of birth in England and Wales, 1964–1996. Data from
Matlai and Beral (1985).
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others to implement with varied success. Some
registries mentioned that the distinction
between glanular and coronal cases was unreli-
able unless made by a pediatric surgeon.
Moreover, the guideline itself was open to var-
ious interpretations, because it specified “glan-
ular or type 1” hypospadias, where type 1 is
often used to refer to both glanular and coro-
nal cases. One of the registers had a policy to
exclude coronal cases, and it is possible that
borderline glanular–coronal cases were vari-
ably excluded by other registries. Our valida-
tion study showed that registers covering a
large number of hospitals and clinicians had
difficulty accurately excluding glanular cases.
In these situations, an exclusion guideline may
simply lead to inconsistency and incomplete-
ness of registration. We conclude that it is
difficult to ensure long-term consistency
and accuracy in the implementation of this
exclusion guideline for surveillance.
At the time this study was done, coding of
congenital anomalies was in the International
Classification of Diseases, 9th revision [ICD-9;
World Health Organization (WHO) 1977],
which did not differentiate location of
hypospadias, a further impediment to imple-
menting the exclusion guideline. Most reg-
istries now employ ICD-10 (WHO 1992),
where location is specified, albeit combining
glanular and coronal hypospadias in one code.
A further important reason mentioned by
registries for not implementing the exclusion
guideline was that the registry did not consider
glanular hypospadias to be in fact minor, given
that a large number of such cases were having
corrective surgery. Different opinions have
been expressed as to the necessity for surgery
for glanular cases (Fichtner et al. 1995), and
the proportion of surgically corrected cases
in the literature is variable. A Danish study
reported 48% of all identified hypospadias
cases born 1983–1993 with a record of surgical
treatment (Weidner et al. 1998). A New York
study for 1983–1995 (Choi et al. 2001) com-
pared a total prevalence of 3.6 per 1,000 births
with a surgical repair rate of 0.6 per 1,000
births, suggesting that only 17% have surgery.
An English study for the period 1992–1994
(Chambers and Malone 1999) based on a sur-
gical series stated a policy to recommend sur-
gery in virtually all cases of hypospadias. A
Finnish study also reported a policy of surgical
correction for minor cases (Aho et al. 2000),
and a small Dutch study for 2000 (Pierik et al.
2002) found that 78% of cases had been rec-
ommended surgery, including one-quarter
of glanular cases. Before the 1980s, a study
in Rochester, New York (USA; Sweet et al.
1974) on a single hospital series for the period
1940–1970 reported a surgical rate of 24%,
with all surgical cases being either penile or
with testicular-associated abnormalities, and an
international registry study (Kallen et al. 1986)
reported surgery for 40% of cases in Hungary
1975, 31% in Sweden 1974, and 27% in
Denmark in 1974–1976. Among EUROCAT
registries, we found two areas (Northern
Ireland and Odense Denmark) where surgery
is rarely recommended for glanular cases, at
least at pre-school age (EUROCAT 2003). We
conclude from this that if surgical policy is an
important criterion in considering which cases
are confirmed or important enough for regis-
tration, there is ample scope for variation in
surgical policy to underlie variation in reported
prevalence rates of hypospadias.
Our validation study suggested that
underascertainment was a particular problem
in the England and Wales NCAS system,
where notification is mainly done by mid-
wives in the first 10 days of life. An estimate
for the period 1972–1978 (Knox et al. 1984)
suggested better sensitivity for hypospadias
before the exclusion guideline was imple-
mented (75 vs. 25% estimated in our study).
In the only previous study considering under-
ascertainment, an international study of reg-
istries (Kallen et al. 1986) estimated that the
proportion of missed cases among those with
surgery was 46% for Hungary (1975), 30%
for Sweden (1974), and 64% for Denmark
(1974–1976). We conclude that access to sur-
gical or hospital discharge records is essential
for high case ascertainment. However, the rel-
atively late age at surgery (≤ 5 years of age) in
some registries implies a consequent delay in
surveillance.
Overascertainment (or incorrect notifica-
tion) of hypospadias may result if registry
information is based on neonatal examinations
by nonspecialists without further verification.
The borderline between incomplete prepuce
and hypospadias may be the most problematic.
We found little evidence of incorrect notifi-
cation in the EUROCAT survey. In the small
England and Wales NCAS sample, 16% of
cases were incorrectly notified as hypospadias,
and a previous study for the 1970s estimated
14% incorrect notifications to the NCAS
(Knox et al. 1984). A previous international
study of registries (Kallen et al. 1986) found
that in Sweden in 1974, 5% of cases were
false positives, and in Hungary in 1975,
21% of cases were false positives. In a recent
Dutch study, Pierik et al. (2002) trained
30 child health center physicians in a stan-
dardized examination of newborns to detect
hypospadias. Of the 60 boys referred to the
pediatric urologist/endocrinologist as cases of
hypospadias, seven had a preputial abnormality
only. A Finnish study found that during a
period when 19 cases of hypospadias were
diagnosed among births in one hospital, seven
additional cases had a foreskin malformation
alone (Virtanen et al. 2001). It could be argued
that incomplete prepuce is not embryologically
or etiologically distinct from hypospadias and
thus should be included in surveillance. We
believe this suggestion is impractical, how-
ever, because the more minor the malforma-
tion, the less likely it is to be consistently and
reliably diagnosed and registered, especially in
the neonatal period, thus giving even more
potential for temporal and geographic varia-
tion. Also, the term “hypospadias” refers to
abnormal position of the meatus, and thus
confusion would arise in including cases with
a normal meatal position.
Most estimates of prevalence in Europe
and the United States range up to a maximum
of 3 per 1,000 births, with two-thirds to three-
quarters of cases being glanular or coronal. Our
estimates from EUROCAT data are within
this range. A Dutch population-based study
reported a higher prevalence of 3.8 per 1,000
(Pierik et al. 2002), which may be partly
related to sensitization to diagnosis by special
training of child health center physicians
for the survey, although the proportion of
distal cases was not higher than usual. A
cohort study in Bristol (North et al. 2000) also
reported a prevalence of 3.2 per 1,000 births,
but cases were not confirmed by pediatric sur-
gical records. The influential early Rochester
single hospital series (Sweet et al. 1974) for
1940–1970 quoted in many pediatric urology
and surgery textbooks reported a relatively high
prevalence of 4 per 1,000 births but also a high
proportion of glanular and coronal cases
(87%), suggesting more complete diagnosis
of glanular cases and/or a shifted boundary
between “normal” and “abnormal.” A German
study of 500 adult men (Fichtner et al. 1995)
found that 13% had hypospadias (equivalent
to a rate of 65 per 1,000 births), of which 75%
had glanular hypospadias, 98% coronal or
glanular. It is probable that the high propor-
tion of glanular hypospadias in this study was
related to measurement and designation of the
“normal/abnormal” boundary in adult men.
We suggest that the three indicators—preva-
lence of hypospadias, proportion of glanular or
coronal cases, and proportion of cases under-
going surgery—are interrelated and must be
interpreted together (Dolk 2004).
Retrospective data validation studies
are difficult to carry out successfully. They
encounter problems of data confidentiality
and protection, resistance of health profession-
als to completing more paperwork, and prob-
lems with retrieval of information and tracing
of cases. Data validation on samples of cases
therefore has to be built into surveillance sys-
tems on a prospective basis. Requirements for
anonymity or patient consent for consultation
of records can greatly increase the difficulty
and expense of carrying out data validation
(Verity and Nicoll 2002).
On the basis of the results of this study,
we recommend the following practice for the
surveillance of hypospadias:
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• All cases of hypospadias should be registered,
regardless of location. Attention should be
given to exclusion of cases of incomplete
prepuce.
• Information on location of hypospadias
should be coded for all cases.
• Surgeons should be among the multiple
sources of case notification and should be
consulted for verification of case status and
meatal location for all cases. This may imply
a delay before reporting prevalence rates for
surveillance purposes, especially in countries
where surgery is conducted later in the first
5 years of life.
• Information on whether surgery has been
recommended or performed should be
recorded.
• Information on whether hypospadias is an
isolated abnormality should be recorded.
• Analyses of trends in prevalence should con-
sider changes in the distribution of location
of recorded isolated cases, as well as changes
in the proportion undergoing surgery by
location.
In light of the above guidelines, surveil-
lance systems could consider whether it is
more cost-effective for hypospadias registra-
tion to be the subject of periodic intensive ad
hoc surveys, or routine registration. This may
depend on the size of the registry, the meth-
ods and sources of information usually used,
and the resources routinely available.
The EUROCAT data do not indicate a
continuing increasing prevalence of hypo-
spadias in Europe since 1980. However, at
present, it is doubtful whether we have the
systems in place worldwide for the effective
surveillance of hypospadias in relation to
concerns regarding exposure to potential
endocrine-disrupting chemicals.
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